High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
about
Risk factors and primary prevention trials for type 1 diabetesInterferon therapy in hepatitis C leading to chronic type 1 diabetesClinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in JapanFrequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional studyAdult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodiesGAD antibody positivity predicts type 2 diabetes in an adult population.Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years.Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID studyVariation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptidePredictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics ConsortiumLatent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-RequirementIgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis.Implication of Cytotoxic Helicobacter pylori Infection in Autoimmune DiabetesGAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patientsMetabolic syndrome and autoimmune diabetes: action LADA 3.Mortality in adult-onset autoimmune diabetes is associated with poor glycemic control: results from the HUNT StudyBeta-cell protection and therapy for latent autoimmune diabetes in adults.Epigenetics in autoimmune diseases with focus on type 1 diabetes.Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy.Relationship between autoantibodies combination, metabolic syndrome components and diabetic complications in autoimmune diabetes in adults.Latent autoimmune diabetes of the adult: current knowledge and uncertaintyIslet Autoantibodies.Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.Latent autoimmune diabetes in adults (LADA) in Asian and European populations.Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA).Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).Autoimmune diabetes in adults and risk of myocardial infarction: the HUNT study in Norway.Glutamic acid decarboxylase and islet antigen 2 antibody profiles in people with adult-onset diabetes mellitus: a comparison between mixed ethnic populations in Singapore and Germany.Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study.Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.Latent autoimmune diabetes in adults in Asians: similarities and differences between East and West.Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study.Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.Adult-onset autoimmune diabetes: current knowledge and implications for management.Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients.Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes.
P2860
Q27005625-ACC3F47E-5802-4669-A682-9C15529E058BQ28080876-130404F5-2A0F-4CB5-BB18-C16EC32AB9D6Q28552055-275CEC5E-B830-4E95-9935-E190D15F0D14Q30414984-5590C24A-41CB-4A17-99FC-BCD94EA13920Q30538087-A747EC15-CF59-4199-905D-67993926333FQ33358948-45E74725-3F9A-4180-93EB-A9AD5130B3F4Q33556707-E5684ECD-E732-42F6-AF20-C54CC12C1C49Q33585748-C44C45DD-49C5-4CFC-A5C1-8867E93E05FBQ33604548-05A04F66-829F-432A-ABEC-E3DE500E44E0Q34084609-56DBA78C-92AC-44C6-AC9C-3A0222E61C7DQ34310431-084B39A2-790B-49E7-8D96-A65C9451BAF1Q34604594-0037E85F-4C18-4F80-BAEE-2C5B8E9C660EQ35108017-93784956-D91F-4060-89E3-C48A8A7FC128Q35740110-21D69EDB-FAB3-4F83-AC8B-01BC4CB93EE2Q36249568-7D94DE12-C1A7-43B3-9B7B-5068E6DC3D61Q36448499-36A806A5-14DE-420F-A0A9-9ABE848C4022Q36807416-DE08E368-2194-4BD9-9495-870D78FB2D1DQ37022978-E0E4720B-DD23-4570-A979-84BEBDC74785Q37331257-160F1A08-E847-4D3E-919C-904839CFCE4DQ37624274-114D0D5B-A5BB-4E82-8CEB-CE25A9B8FB9AQ38062497-5E50D978-FF75-4266-AE78-FA21FBC5F3A5Q38071010-33168276-570C-450D-97DF-18B34B07F4F6Q38223492-F265CAFC-4522-4F30-9E9F-A49A57C771B8Q38324198-60B496BD-F513-4D84-B1B1-40109E04A139Q38817211-0B44ABF3-9998-440A-8339-67683E73327AQ38908327-EA21C870-B47C-4560-B44A-9CAFE1FFE49DQ39136099-197D85C3-A4AB-4B91-A779-BE1A54F3D8B5Q39648112-08A4C02B-2115-4363-9111-87E6B804C746Q40524112-C6D449A1-E8B4-4CE4-99E1-B0239F98CF77Q40533741-DAD7592C-A434-4A8D-9380-EC6A22362770Q41551735-07575B45-BBD5-4242-AF3B-AC19A0DD88C8Q41762781-EB60D5B8-890E-4065-B0B6-53BAB3294C9AQ43589931-460C409A-C88B-4351-A668-A796360193E4Q43819794-9646E84F-A6BD-4C8D-B5D5-C76E78D78C0DQ44299708-C2599A20-7175-497D-B7A5-13A8B571A109Q46085795-BCF21E9B-E1F5-46BD-87CF-D98C47BC00DDQ46463492-CCF3404E-66F9-4DCD-9A5E-EA133774264DQ47694295-DFD5B89F-A054-4C6E-BB2F-AB0D68A4DF7DQ50663436-6F1D8B73-9E15-4D22-B2C1-E505C3B35B43Q51003804-41CA6BB9-EDCA-4967-8866-B496B42AE1EC
P2860
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@en
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@nl
type
label
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@en
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@nl
prefLabel
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@en
High titer of autoantibodies t ...... ult-onset autoimmune diabetes.
@nl
P2093
P356
P1433
P1476
High titer of autoantibodies t ...... dult-onset autoimmune diabetes
@en
P2093
Andrea Giaccari
Antonio Petrone
Concetta Suraci
Elena Bazzigaluppi
Emanuele Bosi
Marco Capizzi
Maria Luisa Arpi
Mattia Locatelli
Non Insulin Requiring Autoimmune Diabetes Study Group
Sergio Di Pietro
P304
P356
10.2337/DC06-1696
P407
P577
2007-04-01T00:00:00Z